Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Cachexia × Clear all

Phase

Status

Sponsor Class

OTHER 112 INDUSTRY 30 NIH 2 OTHER_GOV 1 NETWORK 1 FED 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 46 Colorectal Neoplasms 36 Neoplasms 30 Lung Neoplasms 19 Colonic Neoplasms 13 Breast Neoplasms 13 Colonic Polyps 10 Rare Diseases 8 Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Hepatocellular 7 Ovarian Neoplasms 6 Rectal Neoplasms 5 Motor Activity 5 Heart Failure 5 Adenoma 5 Urinary Bladder Neoplasms 4 Pulmonary Disease, Chronic Obstructive 4 Lung Diseases 4 Liver Neoplasms 4 Fibrosis 4 Esophageal Neoplasms 4 Barrett Esophagus 4 Patient Compliance 3 Obesity 3 Neurologic Manifestations 3 Neoplasms by Site 3 Neoplasm Metastasis 3 Myasthenia Gravis 3 Multiple Myeloma 3 Mental Disorders 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01505764 2018-07-17

The Role of Ghrelin in Cancer Cachexia

VA Office of Research and Development

Phase 2 Terminated

10 enrolled 20 charts

Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡